Amarin Corporation
AMRN
#7965
Rank
A$0.43 B
Marketcap
A$21.05
Share price
3.21%
Change (1 day)
45.59%
Change (1 year)

Earnings for Amarin Corporation (AMRN)

Earnings in 2025 (TTM): -A$0.14 Billion

According to Amarin Corporation 's latest financial reports the company's current earnings are A$0.22 Billion. In 2024 the company made an earning of -A$0.12 Billion a decrease over its 2023 earnings that were of -A$79.9 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Amarin Corporation from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.14 Billion17.3%
2024 -A$0.12 Billion43.84%
2023 -A$79.9 Million-48.3%
2022 -A$0.16 Billion-1019.36%
2021 A$16.8 M-165.44%
2020 -A$25.69 Million-23.25%
2019 -A$33.47 Million-80.68%
2018 -A$0.18 Billion112.25%
2017 -A$81.61 Million-28.23%
2016 -A$0.12 Billion-35.43%
2015 -A$0.18 Billion99.81%
2014 -A$88.13 Million-65.06%
2013 -A$0.26 Billion-0.38%
2012 -A$0.26 Billion-150.87%
2011 A$0.49 B-233.68%
2010 -A$0.38 Billion
2007 -A$58.11 Million44.04%
2006 -A$40.35 Million
2004 -A$21.8 Million-46.41%
2003 -A$40.68 Million-41.09%
2002 -A$69.04 Million813.31%
2001 -A$7.56 Million113.63%
2000 -A$3.54 Million
1998 -A$25.16 Million98.82%
1997 -A$12.66 Million-50.29%
1996 -A$25.46 Million-1321.43%
1995 A$2.08 M-94.53%
1994 A$38.1 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
A$2.47 B-2,050.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.48 B-15,481.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alkermes
ALKS
A$0.60 B-576.62%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
GlaxoSmithKline
GSK
A$13.87 B-11,054.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$2.63 B-2,182.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel